REGN
Companies
NASDAQ
Regeneron Pharmaceuticals, Inc.
Health Care
$511.60
-$198.76 (-27.98%)
Price Chart
Overview
About REGN
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Market Cap
$110.5B
Volume
719.7M
Avg. Volume
663.7M
P/E Ratio
13.568527
Dividend Yield
0.58%
Employees
12.8K
Company Information
Latest News for REGN
Regeneron Pharma Shares Rise Over 3% After Key Signal
June 10, 2025
Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million
May 19, 2025
Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz
June 23, 2025
REGN Stock Undervalued At $500?
June 2, 2025
Regeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal
May 19, 2025
Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid
June 20, 2025
Risk & Correlation Analysis
Market Correlation
0.30
Low Correlation
Volatility
Medium (0.26)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, REGN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$110.5B
Volume719.7M
P/E Ratio13.57
Dividend Yield0.58%
Important Dates
Next Dividend
Next Earnings
April 29, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025